DEBI BOERAS, PH.D – Founder & CEO
The Global Health Impact Group started by Debi Boeras in 2014 was formed in response to the need for stronger partnerships to meet global HIV targets. Debi brings with her over 10 years of HIV experience as a molecular virologist with Professor Eric Hunter and Dr. Susan Allen and then as the Lead for Molecular Diagnostics with Dr. John Nkengasong at the International Laboratory Branch, Centers for Disease Control and Prevention. In Debi’s experience, the most efficient and effective approach to ensure successful programs in HIV diagnosis and monitoring is through strong collaborations. Debi continues to work closely with the African Society for Laboratory Medicine (ASLM), Centers for Disease Control and Prevention (CDC), Clinton Health Access Initiative (CHAI), Doctors Without Borders (MSF), Joint United Nations Programme on HIV/AIDS (UNAIDS), UNITAID, US Agency for International Development (USAID), and World Health Organization (WHO) providing laboratory and programmatic technical support to ensure sustainable early infant diagnosis (EID), viral load (VL), and point-of-care (POC) programs.
BEN CHENG – Chief Strategist & Technical Officer
Ben Cheng has more than 20 years experience working in global public health. Ben’s work has included HIV treatment access and advocacy on clinical research and drug development, HIV drug resistance and pharmacology, addressing stigma and discrimination, strategic planning, and program evaluation. More recently Ben’s focus has been on increasing access to quality assured diagnostics and leveraging new technologies that can be used to improve global public health. Ben has held leadership positions at Pangaea Global AIDS Foundation, PATH, the Forum for Collaborative HIV Research and Project Inform. Ben has served as a member of the FDA’s Blood Product Advisory Committee, the Opportunistic Infections and Primary Infections Committees of the NIH AIDS Clinical Trials Group (ACTG), the WHO Expert Panel to Develop Operations Manual for Delivery of HIV Prevention, Care and Treatment in High Prevalence Resource Constrained Settings, the WHO Infant Diagnosis Working Group, the NIH Rapid HIV Test Working Group, and numerous NIH and FDA review panels and data safety monitoring boards. Ben currently serves on the Board of Directors for the Foundation for AIDS and Immune Research (FAIR) and on the Advisory Board for the Social Entrepreneurship for Sexual Health (SESH) program.
Laura Broyles, MD – Chief of Programs
Laura Broyles, MD is a board-certified infectious diseases physician with over 15 years experience in global HIV programs and clinical HIV care. Her work has included HIV viral load monitoring, early infant diagnosis, HIV drug resistance surveillance and research, elimination of mother-to-child transmission of HIV, differentiated service delivery for PLHIV, and ensuring quality HIV services at the facility level. Prior to joining GHIG, Laura spent eight years in the Division of Global HIV and TB (DGHT) at CDC headquarters in Atlanta, where she served most recently as Chief of the Maternal and Child Health Branch. Dr. Broyles served as an Epidemic Intelligence Service Officer in the CDC Division of HIV/AIDS Prevention from 2001-2003 after completing residency in internal medicine. She has been on the faculty of the Emory University Division of Infectious Diseases since 2006 and continues to do clinical work at the Grady Infectious Diseases Program.
ROBERT LUO, MD, MPH – Chief Medical Officer
Dr. Robert Luo, MD, MPH is a board-certified pathologist who has worked on diagnostics over the last 15 years across academia, public health, and industry. Dr. Luo received his BA from Harvard University and his MD and MPH from Johns Hopkins University, before completing his residency training in anatomic and clinical pathology at Stanford University. After residency, he worked at the US Centers for Disease Control and Prevention, Stanford University Medical Center, and most recently at Roche Molecular Diagnostics, where he served as a medical director for over 10 new diagnostic assays. His work on diagnostics and infectious diseases has been published in JAMA, Lancet, and numerous other scientific journals. He has lived and worked in a variety of settings, including the US, South Africa, China, Kenya, India, Peru, Vietnam, Malaysia, and North Korea.